Mitral Valve Clinical Trials: Surgeon Q&A with Dr. Pavan Atluri (Penn Medicine)

https://www.Heart-Valve-Surgery.com - According to a new patient survey, 73% of heart valve patients are "not very aware" of clinical trials for heart valve disease. For that reason, we interviewed Dr. Pavan Atluri, the Director of Minimally Invasive and Robotic Cardiac Surgery at Penn Medicine Heart and Vascular Center in Philadelphia, Pennsylvania. Dr. Atluri is currently working on many different clinical trial for mitral valve therapy research including new non-invasive, transcatheter devices. Watch this video to get answers to these important questions:

1. How are clinical trials transforming heart valve surgery?
2. What impact has transcatheter aortic valve replacement (TAVR) clinical trials had on other types of valve therapy for the mitral, tricuspid and pulmonary valves?
3. Why is there so much clinical trial activity specific to the mitral valve?
4. What should patients know about clinical trials for mitral valve repair?
5. How has the complexity of the mitral valve impacted clinical trial development and commercialization?
6. What are the latest updates for clinical trials specific to transcatheter mitral valve replacement (TMVR)?
7. What is the future of clinical trials for the mitral valve?

During his career, Dr. Atluri has performed over 5,000 cardiac procedures of which 2,000 involved heart valve therapy. To see patient reviews and a complete surgeon biography of Dr. Atluri, please visit https://www.heart-valve-surgery.com/s....